gliclazide and glucose, (beta-d)-isomer

gliclazide has been researched along with glucose, (beta-d)-isomer in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Bilz, S; Brändle, M; Fournier, JY; Quarella, M; Walser, D1
Avogaro, A; Baldi, I; Bottigliengo, D; Consoli, A; Fadini, GP; Giaccari, A; Sesti, G; Zatti, G1
Bhutani, R; Bodla, RB; Kant, R; Kapoor, G1
Detsch, JM; Lacerda, CS; Marino, EC; Marques, K; Pechmann, LM; Polesel, MG; Sanches, CP; Scharf, M; Vianna, AGD1
Bozovic, A; Danser, AHJ; Emanuel, AL; Geurts, F; Hoorn, EJ; Joles, JA; Kramer, MHH; Larsen, EL; Muskiet, MHA; Nieuwdorp, M; Poulsen, HE; Smits, MM; Tonneijck, L; Touw, DJ; van Baar, MJB; van Bommel, EJM; van Raalte, DH1
Davids, M; Herrema, H; Kramer, MHH; Nieuwdorp, M; van Bommel, EJM; van Raalte, DH1
Abdel-Latif, RG; Amin, EF; Rifaai, RA1
Heerspink, HJL; Joles, JA; Kramer, MHH; Muskiet, MHA; Nieuwdorp, M; Ruiter, D; Smits, MM; Touw, DJ; van Bommel, EJM; van Raalte, DH1
Bakker, SJL; Danser, AHJ; Ferrannini, E; Geurts, F; Hoorn, EJ; Joles, JA; Kramer, MHH; Muskiet, MHA; Nieuwdorp, M; Post, A; Touw, DJ; van Berkel, M; van Bommel, EJM; van Raalte, DH1
Gong, M; He, R; Li, J; Ma, T; Peng, J; Xu, Y1

Trials

5 trial(s) available for gliclazide and glucose, (beta-d)-isomer

ArticleYear
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial.
    Diabetes, obesity & metabolism, 2020, Volume: 22, Issue:4

    Topics: Aged; Benzhydryl Compounds; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Female; Gliclazide; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged

2020
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
    Kidney international, 2020, Volume: 97, Issue:1

    Topics: Aged; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Gliclazide; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Kidney; Male; Metformin; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Vasoconstriction; Vasodilation

2020
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
    Diabetes & metabolism, 2020, Volume: 46, Issue:2

    Topics: Adult; Aged; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Feces; Female; Gastrointestinal Microbiome; Gliclazide; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors

2020
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes.
    Journal of hypertension, 2020, Volume: 38, Issue:9

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Gliclazide; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Vascular Stiffness

2020
SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes.
    Clinical science (London, England : 1979), 2020, 12-11, Volume: 134, Issue:23

    Topics: Acid-Base Equilibrium; Ammonium Compounds; Benzhydryl Compounds; Bicarbonates; Blood Glucose; Citrates; Diabetes Mellitus, Type 2; Electrolytes; Female; Gliclazide; Glomerular Filtration Rate; Glucosides; Humans; Hydrogen-Ion Concentration; Ketones; Kidney Tubules; Male; Middle Aged; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds

2020

Other Studies

5 other study(ies) available for gliclazide and glucose, (beta-d)-isomer

ArticleYear
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly.
    The Journal of clinical endocrinology and metabolism, 2017, 05-01, Volume: 102, Issue:5

    Topics: Adenoma; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combination; Fatty Acids, Nonesterified; Gliclazide; Glucagon; Glucosides; Growth Hormone-Secreting Pituitary Adenoma; Humans; Hypoglycemic Agents; Insulin; Ketone Bodies; Male; Metformin; Middle Aged; Severity of Illness Index; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors

2017
Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study.
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:7

    Topics: Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gliclazide; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Italy; Male; Middle Aged; Retrospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome

2018
Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.
    Bioorganic chemistry, 2019, Volume: 91

    Topics: Adamantane; Benzhydryl Compounds; Chromatography, High Pressure Liquid; Dipeptides; Dose-Response Relationship, Drug; Gliclazide; Glucosides; Linagliptin; Metformin; Molecular Structure; Pioglitazone; Pyrazoles; Software; Structure-Activity Relationship; Thiazolidines

2019
Empagliflozin attenuates transient cerebral ischemia/reperfusion injury in hyperglycemic rats via repressing oxidative-inflammatory-apoptotic pathway.
    Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:5

    Topics: Animals; Apoptosis; Benzhydryl Compounds; Disease Models, Animal; Gliclazide; Glucosides; Hyperglycemia; Hypoglycemic Agents; Inflammation; Ischemic Attack, Transient; Male; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar

2020
The effects of 18β-glycyrrhetinic acid and glycyrrhizin on intestinal absorption of paeoniflorin using the everted rat gut sac model.
    Journal of natural medicines, 2017, Volume: 71, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drugs, Chinese Herbal; Glucosides; Glycyrrhetinic Acid; Glycyrrhizic Acid; Intestinal Mucosa; Male; Monoterpenes; Rats; Rats, Sprague-Dawley

2017